Patents by Inventor Gilles Briault

Gilles Briault has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9856221
    Abstract: Ivabradine hemipamoate of formula (I): and its hydrates. Medicinal products containing the same which are useful in the treatment or prevention of the various clinical situations of myocardial ischaemia such as angina pectoris, myocardial infarction and the associated rhythm disturbances, as well as in the various pathologies involving rhythm disturbances, especially supraventricular rhythm disturbances, and in systolic or diastolic heart failure.
    Type: Grant
    Filed: May 6, 2015
    Date of Patent: January 2, 2018
    Assignee: LES LABORATOIRES SERVIER
    Inventors: Michael Lynch, Patrick Cointepas, David Lafargue, Gilles Briault
  • Publication number: 20170050932
    Abstract: Ivabradine hemipamoate of formula (1): and its hydrates. Medicinal products containing the same which are useful in the treatment or prevention of the various clinical situations of myocardial ischaemia such as angina pectoris, myocardial infarction and the associated rhythm disturbances, as well as in the various pathologies involving rhythm disturbances, especially supraventricular rhythm disturbances, and in systolic or diastolic heart failure.
    Type: Application
    Filed: May 6, 2015
    Publication date: February 23, 2017
    Inventors: Michael LYNCH, Patrick COINTEPAS, David LAFARGUE, Gilles BRIAULT
  • Publication number: 20110130370
    Abstract: A pharmaceutical composition comprising a strontium salt, vitamin D and a cyclodextrin.
    Type: Application
    Filed: November 23, 2010
    Publication date: June 2, 2011
    Applicant: LES LABORATORIES SERVIER
    Inventors: Gilles Briault, Xavier Quenault, Cécile Poirier, Jean-Manuel Pean
  • Publication number: 20040115227
    Abstract: The present invention relates to a new solid controlled-release pharmaceutical composition obtained by thermoforming, in the hot state, a mixture based on polymers belonging to the polymethacrylate family and perindopril or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: June 26, 2003
    Publication date: June 17, 2004
    Inventors: Patrick Wuthrich, Herve Rolland, Gilles Briault, Gerald Pichon, Francois Tharrault
  • Publication number: 20040028743
    Abstract: The present invention relates to a new solid controlled-release pharmaceutical composition obtained by thermoforming, in the hot state, a mixture based on polymers belonging to the polymethacrylate family and ivabradine or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: June 26, 2003
    Publication date: February 12, 2004
    Inventors: Patrick Wuthrich, Herve Rolland, Gilles Briault, Gerald Pichon, Francois Tharrault
  • Patent number: 6319520
    Abstract: The present invention relates to a new solid controlled-release pharmaceutical composition obtained by thermoforming, in the hot state, a mixture based on polymers belonging to the polymethacrylate family and medicinal active ingredient(s).
    Type: Grant
    Filed: June 27, 2000
    Date of Patent: November 20, 2001
    Assignee: Adir et Compagnie
    Inventors: Patrick Wuthrich, Hervé Rolland, Gilles Briault, Gérald Pichon, François Tharrault